ADVB · Advanced Biomed Inc.
$5.03
+0.13 (+2.65%)
At close · Jul 17
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$6.95M
Shares
1,382,133
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mingze Yin | CFO | — |
| Yi Lu | CEO | — |
| Steven I-Fang Cheng | CTO | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mingze Yin | CFO | — |
| Steven I-Fang Cheng | CTO | — |
| Yi Lu | CEO | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Xiaomin Chen | Chairman of the Board | Appointed | 2026-05-01 |
| Xiaomin Chen | director | Appointed | 2026-05-01 |
| Xiaomin Chen | Chief Executive Officer | Appointed | 2026-05-01 |
Key facts
CIK
1941029
CUSIP
00752P203